Angiotensin receptor blockers and endpoint protection.
Kjeldsen
Sverre E
SE
Hedner
Thomas
T
Narkiewicz
Krzysztof
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide